Skye Bioscience, Inc.
SKYE
$1.11
-$0.10-8.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.31M | 48.59M | 59.22M | 68.42M | 67.41M |
| Total Receivables | 16.80K | 13.50K | 14.60K | 13.20K | 12.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.71M | 1.26M | 575.40K | 202.00K | 664.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 883.40K | 719.90K | 3.21M | 2.20M | 11.72M |
| Total Current Assets | 39.92M | 50.58M | 63.03M | 70.83M | 79.81M |
|
|
|||||
| Total Current Assets | 39.92M | 50.58M | 63.03M | 70.83M | 79.81M |
| Net Property, Plant & Equipment | 1.35M | 1.52M | 1.71M | 1.88M | 1.70M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 53.90K | 53.90K | 53.90K | 53.90K | 26.30K |
| Total Assets | 41.32M | 52.16M | 64.79M | 72.76M | 81.54M |
|
|
|||||
| Total Accounts Payable | 2.83M | 3.22M | 1.71M | 569.30K | 780.00K |
| Total Accrued Expenses | 3.29M | 3.09M | 1.50M | 1.77M | 2.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 201.60K | 195.00K | 188.60K | 182.40K | 82.90K |
| Total Finance Division Other Current Liabilities | 2.05M | 1.81M | 1.91M | 1.82M | 1.79M |
| Total Other Current Liabilities | 2.05M | 1.81M | 1.91M | 1.82M | 1.79M |
| Total Current Liabilities | 8.37M | 8.31M | 5.32M | 4.34M | 5.62M |
|
|
|||||
| Total Current Liabilities | 8.37M | 8.31M | 5.32M | 4.34M | 5.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 120.20K | 172.50K | 223.50K | 273.20K | 108.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.49M | 8.48M | 5.54M | 4.61M | 5.73M |
|
|
|||||
| Common Stock & APIC | 205.27M | 203.35M | 201.30M | 199.10M | 197.01M |
| Retained Earnings | -172.43M | -159.68M | -142.05M | -130.95M | -121.20M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 32.84M | 43.68M | 59.25M | 68.15M | 75.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.84M | 43.68M | 59.25M | 68.15M | 75.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.84M | 43.68M | 59.25M | 68.15M | 75.80M |
|
|
|||||